Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer effects on lipid metabolism

Clinical study on chlormadinone acetate alone followed by combination with LH-RH analogue for prostatic cancer : effects on lipid metabolism

Twenty-four previously untreated patients with a diagnosis of prostatic cancer were treated with chlormadinone acetate (CMA) alone (100 mg/day) for 4 weeks, and luteinizing hormone-releasing hormone analogue (LH-RHa) was added for the next 24 weeks. Marked decreases in blood LH, testosterone (T), pr...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 44(1998), 7 vom: 05. Juli, Seite 525-32
1. Verfasser: Shimada, M (VerfasserIn)
Weitere Verfasser: Uchida, H, Kasahara, T, Fuji, K, Ogawa, Y, Yoshida, H, Hamajima, T, Matsuda, N, Ikeuchi, T, Kai, Y, Hiramori, M, Hoshino, M, Inoue, K, Higaki, Y
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1998
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial English Abstract Journal Article Antineoplastic Agents, Hormonal Apolipoproteins Progesterone Congeners Triglycerides Chlormadinone Acetate 0SY050L61N Testosterone mehr... 3XMK78S47O Cholesterol 97C5T2UQ7J Prostate-Specific Antigen EC 3.4.21.77 Leuprolide EFY6W0M8TG